Ładuje się......
PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
INTRODUCTION: Prenylated Rab acceptor 1 domain family member 2 (PRAF2), a novel oncogene, has been shown to be essential for the development of several human cancers; however, its role in hepatocellular carcinoma (HCC) remains unclear. MATERIALS AND METHODS: PRAF2 mRNA and protein expressions were e...
Zapisane w:
| Wydane w: | Cancer Manag Res |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Dove Medical Press
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065608/ https://ncbi.nlm.nih.gov/pubmed/30100755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S166789 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|